News | Radiation Therapy | May 19, 2017

ASTRO's 59th Annual Meeting Will Explore Art and Science of Radiation Oncology

San Diego meeting will highlight more than 2,800 abstracts featuring advances in cancer research and clinical care

ASTRO's 59th Annual Meeting Will Explore Art and Science of Radiation Oncology

May 19, 2017 — Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which will highlight advances in cancer research and clinical care involving radiation therapy. The meeting, which will be held Sept. 24–27 at the San Diego Convention Center, is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

More than 2,800 abstracts sharing results from clinical trials and other research studies will be presented in conjunction with educational sessions and keynote addresses that underscore the meeting’s theme, “The Healing Art and Science of Radiation Oncology.” Keynote speakers include:

  • Richard D. Zane, M.D., FAAEM, chief innovation officer for the University of Colorado Health System (Monday, Sept. 25);
  • Lucy Kalanithi, M.D., FACP, widow of Paul Kalanithi, M.D., the best-selling author of “When Breath Becomes Air,” with Heather Wakelee, M.D., her late husband’s oncologist (Tuesday, Sept. 26); and
  • Vinay K. Prasad, M.D., MPH, assistant professor of medicine, Oregon Health & Science University (Wednesday, September 27).

At the same time as the scientific and educational program, more than 200 exhibitors will demonstrate cutting-edge technology and medical device innovations for radiation oncology. New this year, daily science highlight sessions will spotlight the highest-rated studies grouped by cancer type (e.g., breast cancer, lung cancer).

For more information: www.astro.org

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...